Yifan Pharmaceutical Co., Ltd. (002019.SZ)
CNY 11.34
(-2.99%)
CNY 11.34
(-2.99%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.82 Billion CNY | 19.44% |
| 2022 | 1.52 Billion CNY | 3.3% |
| 2021 | 1.47 Billion CNY | 10.54% |
| 2020 | 1.33 Billion CNY | 11.49% |
| 2019 | 1.19 Billion CNY | 13.87% |
| 2018 | 1.05 Billion CNY | 25.33% |
| 2017 | 839.43 Million CNY | 5.44% |
| 2016 | 796.08 Million CNY | 38.44% |
| 2015 | 575.03 Million CNY | 56.85% |
| 2014 | 366.61 Million CNY | 179.42% |
| 2013 | 131.2 Million CNY | 4.08% |
| 2012 | 126.05 Million CNY | -9.41% |
| 2011 | 139.15 Million CNY | 13.83% |
| 2010 | 122.24 Million CNY | 28.16% |
| 2009 | 95.38 Million CNY | -25.53% |
| 2008 | 128.08 Million CNY | 9.92% |
| 2007 | 116.52 Million CNY | 20.5% |
| 2006 | 96.7 Million CNY | 123.89% |
| 2005 | 43.19 Million CNY | 6.43% |
| 2004 | 40.58 Million CNY | 74.29% |
| 2003 | 23.28 Million CNY | 40.15% |
| 2002 | 16.61 Million CNY | 70.09% |
| 2001 | 9.76 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 507.6 Million CNY | 0.32% |
| 2024 Q1 | 484.74 Million CNY | -66.58% |
| 2024 Q2 | 487.33 Million CNY | 0.53% |
| 2023 FY | 1.82 Billion CNY | 19.44% |
| 2023 Q2 | 409.96 Million CNY | 5.28% |
| 2023 Q1 | 389.4 Million CNY | 3.2% |
| 2023 Q3 | 438.77 Million CNY | 7.03% |
| 2023 Q4 | 1.45 Billion CNY | 230.57% |
| 2022 Q1 | 320.6 Million CNY | -28.07% |
| 2022 FY | 1.52 Billion CNY | 3.3% |
| 2022 Q2 | 390.18 Million CNY | 21.7% |
| 2022 Q4 | 377.31 Million CNY | -13.63% |
| 2022 Q3 | 436.85 Million CNY | 11.96% |
| 2021 Q4 | 445.71 Million CNY | 29.91% |
| 2021 Q2 | 360.56 Million CNY | 10.29% |
| 2021 Q3 | 343.08 Million CNY | -4.85% |
| 2021 Q1 | 326.92 Million CNY | -21.77% |
| 2021 FY | 1.47 Billion CNY | 10.54% |
| 2020 FY | 1.33 Billion CNY | 11.49% |
| 2020 Q4 | 417.92 Million CNY | 37.63% |
| 2020 Q3 | 303.66 Million CNY | 5.37% |
| 2020 Q2 | 288.17 Million CNY | -10.32% |
| 2020 Q1 | 321.34 Million CNY | -18.46% |
| 2019 Q1 | 253.26 Million CNY | -23.89% |
| 2019 Q2 | 215.78 Million CNY | -14.8% |
| 2019 Q3 | 328.81 Million CNY | 52.38% |
| 2019 Q4 | 394.08 Million CNY | 19.85% |
| 2019 FY | 1.19 Billion CNY | 13.87% |
| 2018 Q4 | 332.75 Million CNY | 31.63% |
| 2018 Q3 | 252.79 Million CNY | 24.99% |
| 2018 FY | 1.05 Billion CNY | 25.33% |
| 2018 Q1 | 259.18 Million CNY | 1.68% |
| 2018 Q2 | 202.25 Million CNY | -21.96% |
| 2017 Q4 | 254.89 Million CNY | 24.03% |
| 2017 Q3 | 205.51 Million CNY | 25.92% |
| 2017 Q2 | 163.21 Million CNY | -24.37% |
| 2017 Q1 | 215.81 Million CNY | -17.89% |
| 2017 FY | 839.43 Million CNY | 5.44% |
| 2016 Q3 | 185.86 Million CNY | 12.38% |
| 2016 Q2 | 165.39 Million CNY | -9.12% |
| 2016 Q1 | 181.98 Million CNY | 14.26% |
| 2016 Q4 | 262.84 Million CNY | 41.42% |
| 2016 FY | 796.08 Million CNY | 38.44% |
| 2015 FY | 575.03 Million CNY | 56.85% |
| 2015 Q3 | 161.37 Million CNY | 23.07% |
| 2015 Q4 | 159.26 Million CNY | -1.31% |
| 2015 Q2 | 131.12 Million CNY | 6.37% |
| 2015 Q1 | 123.26 Million CNY | 0.27% |
| 2014 Q1 | 36.96 Million CNY | -14.83% |
| 2014 Q3 | 95.13 Million CNY | 87.16% |
| 2014 Q4 | 122.94 Million CNY | 29.23% |
| 2014 FY | 366.61 Million CNY | 179.42% |
| 2014 Q2 | 50.83 Million CNY | 37.51% |
| 2013 FY | 131.2 Million CNY | 4.08% |
| 2013 Q2 | 31.38 Million CNY | 17.97% |
| 2013 Q3 | 29.82 Million CNY | -4.97% |
| 2013 Q4 | 43.4 Million CNY | 45.54% |
| 2013 Q1 | 26.6 Million CNY | -33.29% |
| 2012 Q2 | 29.45 Million CNY | 16.57% |
| 2012 Q1 | 25.26 Million CNY | -52.71% |
| 2012 Q4 | 39.87 Million CNY | 26.78% |
| 2012 FY | 126.05 Million CNY | -9.41% |
| 2012 Q3 | 31.45 Million CNY | 6.78% |
| 2011 Q4 | 53.43 Million CNY | 98.03% |
| 2011 FY | 139.15 Million CNY | 13.83% |
| 2011 Q1 | 30.07 Million CNY | -24.49% |
| 2011 Q2 | 28.66 Million CNY | -4.67% |
| 2011 Q3 | 26.98 Million CNY | -5.88% |
| 2010 Q2 | 25.69 Million CNY | -4.46% |
| 2010 Q4 | 39.82 Million CNY | 33.53% |
| 2010 FY | 122.24 Million CNY | 28.16% |
| 2010 Q1 | 26.89 Million CNY | -1.6% |
| 2010 Q3 | 29.82 Million CNY | 16.06% |
| 2009 Q2 | 24.5 Million CNY | 39.43% |
| 2009 Q1 | 17.57 Million CNY | -61.92% |
| 2009 FY | 95.38 Million CNY | -25.53% |
| 2009 Q4 | 27.33 Million CNY | 5.24% |
| 2009 Q3 | 25.97 Million CNY | 6.01% |
| 2008 Q4 | 46.14 Million CNY | 98.0% |
| 2008 Q2 | 26.5 Million CNY | -17.52% |
| 2008 Q3 | 23.3 Million CNY | -12.07% |
| 2008 Q1 | 32.13 Million CNY | 4.23% |
| 2008 FY | 128.08 Million CNY | 9.92% |
| 2007 Q2 | 22.99 Million CNY | -24.0% |
| 2007 FY | 116.52 Million CNY | 20.5% |
| 2007 Q4 | 30.83 Million CNY | -4.99% |
| 2007 Q3 | 32.45 Million CNY | 41.13% |
| 2007 Q1 | 30.25 Million CNY | -21.44% |
| 2006 Q3 | 22.9 Million CNY | 21.44% |
| 2006 Q1 | 16.43 Million CNY | 74.43% |
| 2006 FY | 96.7 Million CNY | 123.89% |
| 2006 Q2 | 18.85 Million CNY | 14.75% |
| 2006 Q4 | 38.5 Million CNY | 68.16% |
| 2005 Q4 | 9.42 Million CNY | -33.24% |
| 2005 FY | 43.19 Million CNY | 6.43% |
| 2005 Q2 | 13.16 Million CNY | 102.5% |
| 2005 Q1 | 6.49 Million CNY | -32.74% |
| 2005 Q3 | 14.11 Million CNY | 7.22% |
| 2004 Q4 | 9.66 Million CNY | -39.89% |
| 2004 FY | 40.58 Million CNY | 74.29% |
| 2004 Q1 | 8.49 Million CNY | -1.43% |
| 2004 Q2 | 6.35 Million CNY | -25.18% |
| 2004 Q3 | 16.07 Million CNY | 153.05% |
| 2003 Q3 | 4.72 Million CNY | 0.0% |
| 2003 Q4 | 8.61 Million CNY | 82.32% |
| 2003 FY | 23.28 Million CNY | 40.15% |
| 2002 FY | 16.61 Million CNY | 70.09% |
| 2001 FY | 9.76 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 1.36 Billion CNY | -107.4% |
| Zhejiang Zhenyuan Share Co., Ltd. | 654.18 Million CNY | -332.429% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 548.76 Million CNY | -415.497% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 343.25 Million CNY | -724.142% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 307.2 Million CNY | -820.848% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 7.5 Billion CNY | 62.326% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 564.68 Million CNY | -400.965% |
| Boai NKY Medical Holdings Ltd. | 309.15 Million CNY | -815.048% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 463.02 Million CNY | -510.954% |